NanoKnife Approved for IDE Study

A recent device is ready for trial in the U.S which can be a boon for precision ablation of prostate tumors and this could a good shot in the arm for clinicians.

A recent device is ready for trial in the U.S which can be a boon for precision ablation of prostate tumors and this could be a good shot in the arm for clinicians.

The NanoKnife from AngioDynamics specializes in irreversible electroporation which is nothing but initiating a powerful electric field with a combination of electrodes.

Prostate Specific Antigen [PSA] & Prostate Cancer Diagnosis
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.

This device enables the entry of ions into the cell interiors and leads to permanent necrosis.

AngioDynamics has not received the FDA approval but they have been given the go ahead with an Investigational Device Exemption (IDE) trial of the NanoKnife for focal treatment of prostate cancer.

Prostate Cancer Screening
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.

Source-Medindia

Prostate Cancer: Treatment Options - Surgery, Radiation Therapy, Hormone Therapy
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy.